® inhaler, the pharmaceutical company's innovative, patented, dry powder inhaler. Propeller Health is to enter into to a research and development collaboration with pharmaceutical manufacturer GlaxoSmithKline to test a custom sensor for the companies Ellipta inhaler for COPD . GSK will conduct a number of studies of patients with COPD , monitoring the patient 's adherence remotely with help from the sensors , which will provide greater insights into how patients interact with their inhalers , and may allow for more precise correlation of adherence with safety , health and economic outcomes . Propeller 's monitoring system is becoming increasingly widely used in the US healthcare sector , with over 35 commercial programmes using the technology .
Propeller Health is to enter into to a research and development collaboration with pharmaceutical manufacturer GlaxoSmithKline to test a custom sensor for the companies Ellipta inhaler for COPD . GSK will conduct a number of studies of patients with COPD , monitoring the patient 's adherence remotely with help from the sensors , which will provide greater insights into how patients interact with their inhalers , and may allow for more precise correlation of adherence with safety , health and economic outcomes . Propeller 's monitoring system is becoming increasingly widely used in the US healthcare sector , with over 35 commercial programmes using the technology .